Salidroside promotes human periodontal ligament cell proliferation and osteocalcin secretion via ERK1/2 and PI3K/Akt signaling pathways

  • Authors:
    • Yukang Ying
    • Jun Luo
  • View Affiliations

  • Published online on: March 29, 2018     https://doi.org/10.3892/etm.2018.6006
  • Pages: 5041-5045
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Salidroside modulates cell proliferation and serves as an anti‑inflammatory and anti‑apoptotic agent with efficacy against various diseases. The objective of the present study was to investigate the efficacy of salidroside in enhancing the proliferation of human periodontal ligament cells (hPDLCs). hPDLCs were isolated and the effects of salidroside on cell viability, soluble osteocalcin levels and activation of proliferation‑associated signaling pathways were determined using a CCK‑8 assay, ELISA and Western blotting, respectively. The results indicated that salidroside induced proliferation of hPDLCs, increased secretion of soluble osteocalcin and enhanced activation of extracellular signal‑regulated kinase (ERK)1/2 and phosphoinositide‑3 kinase (PI3K)/Akt signaling pathways. These factors were upregulated by salidroside in a dose‑dependent manner. The results of the present study suggested that salidroside mediated hPDLC proliferation via the ERK1/2 and PI3K/Akt signaling pathways, as well as osteocalcin secretion. Salidroside may therefore be used as a novel therapeutic agent in the treatment of the tooth‑supporting apparatus, progressive tooth destruction or periodontitis.
View Figures
View References

Related Articles

Journal Cover

June-2018
Volume 15 Issue 6

Print ISSN: 1792-0981
Online ISSN:1792-1015

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Ying Y and Ying Y: Salidroside promotes human periodontal ligament cell proliferation and osteocalcin secretion via ERK1/2 and PI3K/Akt signaling pathways. Exp Ther Med 15: 5041-5045, 2018
APA
Ying, Y., & Ying, Y. (2018). Salidroside promotes human periodontal ligament cell proliferation and osteocalcin secretion via ERK1/2 and PI3K/Akt signaling pathways. Experimental and Therapeutic Medicine, 15, 5041-5045. https://doi.org/10.3892/etm.2018.6006
MLA
Ying, Y., Luo, J."Salidroside promotes human periodontal ligament cell proliferation and osteocalcin secretion via ERK1/2 and PI3K/Akt signaling pathways". Experimental and Therapeutic Medicine 15.6 (2018): 5041-5045.
Chicago
Ying, Y., Luo, J."Salidroside promotes human periodontal ligament cell proliferation and osteocalcin secretion via ERK1/2 and PI3K/Akt signaling pathways". Experimental and Therapeutic Medicine 15, no. 6 (2018): 5041-5045. https://doi.org/10.3892/etm.2018.6006